Inflair Elevate Spf15 Moisturizer Cream
NDC Package 87582-002-01
Package Information
Inflair Elevate Spf15 Moisturizer (ethylhexyl methoxycinnamate ethylhexyl salicylate homosalate butyl methoxydibenzoylmethane) cream is skin Cancer/Skin Aging Alert: Spending time in the sun increases your risk ofskin cancer and early skin aging. This formulation utilizes a cream delivery system. Marketed by Guangzhou Yapheon Health Industry Co., Ltd, this product is identified by NDC 87582-002 and is authorized under FDA application M020.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 87582 - Guangzhou Yapheon Health Industry Co., Ltd
- 87582-002 - Inflair Elevate Spf15 Moisturizer
- 87582-002-01 - 50 g in 1 BOTTLE
- 87582-002 - Inflair Elevate Spf15 Moisturizer
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (87582-002). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 87582-002-01 identifies a specific commercial package of 50 g in 1 bottle of Inflair Elevate Spf15 Moisturizer, a human over the counter drug labeled by Guangzhou Yapheon Health Industry Co., Ltd. This cream is formulated for topical use and contains butyl methoxydibenzoylmethane; ethylhexyl methoxycinnamate; ethylhexyl salicylate; homosalate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guangzhou Yapheon Health Industry Co., Ltd on June 07, 2026. The current certification is valid through December 31, 2027.
How is this Guangzhou Yapheon Health Industry Co., Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 87582000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.